XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 28, 2025
Dec. 29, 2024
Current assets    
Cash and cash equivalents $ 1,139 $ 1,070
Trade receivables, less allowances for credit losses (($25) and $26 as of September 28, 2025 and December 29, 2024, respectively) 2,416 2,165
Inventories 1,794 1,591
Prepaid expenses and other receivables 531 494
Other current assets 152 205
Total current assets 6,032 5,525
Property, plant, and equipment, net 2,092 1,849
Intangible assets, net 8,716 8,474
Goodwill 9,441 8,843
Deferred taxes on income 237 184
Other Assets, Noncurrent 730 726
Total assets 27,248 25,601
Current liabilities    
Loans and notes payable 1,913 1,552
Accounts payable 2,445 2,254
Accrued liabilities 958 1,132
Accrued rebates, returns, and promotions 737 727
Accrued taxes on income 103 74
Total current liabilities 6,156 5,739
Total long-term debt 7,060 7,055
Deferred taxes on income 2,425 2,261
Employee-related obligations 373 342
Other liabilities 600 536
Total liabilities 16,614 15,933
Commitments and contingencies (Note 13)
Stockholders’ Equity    
Preferred stock, $0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of September 28, 2025 and December 29, 2024 0 0
Common stock, $0.01 par value, 12,500,000 shares authorized; 1,936,118 and 1,915,731 shares issued and outstanding as of September 28, 2025, respectively; 1,924,977 and 1,913,768 shares issued and outstanding as of December 29, 2024, respectively 19 19
Additional paid-in capital 16,320 16,130
Treasury stock, 20,387 and 11,208 shares at cost as of September 28, 2025 and December 29, 2024, respectively (439) (242)
Accumulated deficit (136) (93)
Accumulated other comprehensive loss (5,130) (6,146)
Total stockholders’ equity 10,634 9,668
Total Liabilities and Stockholders’ Equity $ 27,248 $ 25,601